Inherited peripheral neuropathies

Neurologist

Volumn 3, Issue 5, 1997, Pages 277-292

  Lynch, David R ^a,b   Chance, Phillip F ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Amyloid; Charcot Marie Tooth neuropathy; Mitochondrial disease; P0; PMP22; Refsum's disease

Indexed keywords

EID: 0007120556     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00127893-199709000-00001     Document Type: Article

References (194)

1. Navon R, Timmerman V, Lofgren A, Liang P, Nelis E, Zeitune M, et al. Prenatal diagnosis of Charcot-Marie-Tooth disease type 1A (CMT1A) using molecular genetic techniques. Prenatal Diag 1995;15:633-40.
2. Lebo RV, Martelli L, Su Y, Li L, Lynch E, Mansfield E, et al. Prenatal diagnosis of Charcot-Marie-Tooth disease type 1A by multicolor in situ hybridization. Am J Med Genet 1993;47:441-50.
3. Mostacciuolo ML, Micaglio G, Fardin P, Danieli GA. Genetic epidemiology of hereditary motor an sensory neuropathies (type I). Am J Med Genet 1991;39:479-81.
4. Mostacciuolo ML, Schiavon F, Angelini C, Miccoli B, Piccolo F, Danieli GA. Frequency of duplication at 17p11.2 in families of northeast Italy with Charcot-Marie-Tooth disease type 1. Neuroepidemiology 1995;14:49-53.
5. Feasby TE, Hahn AF, Bolton CF, Brown WF, Koopman WJ. Detection of hereditary motor sensory neuropathy type I in childhood. J Neurol Neurosurg Psychiatry 1992;55:895-7.
6. Carter GT, Kilmer DD, Bonekat HW, Lieberman JS, Fowler WM Jr. Evaluation of phrenic nerve and pulmonary function in hereditary motor and sensory neuropathy, type I. Muscle Nerve 1992;15:459-62.
7. Bird TD, Lipe HP, Crabtree LD. Impotence associated with the Charcot-Marie-Tooth syndrome. Eur Neurol 1994;34:155-7.
8. Hardie R, Harding AE, Hirsch N, Gelder C, Macrae AD, Thomas PK. Diaphragmatic weakness in hereditary motor and sensory neuropathy. J Neurol Neurosurg Psychiatry 1990;53:348-50.
9. Cardoso FE, Jankovic J. Hereditary motor-sensory neuropathy and movement disorders. Muscle Nerve 1993;16:904-10.
10. Barbieri F, Filla A, Ragno M, Crisci C, Santoro L, Corona M, et al. Evidence that Charcot-Marie-Tooth disease with tremor coincides with the Roussy-Levy syndrome. Can J Neurol Sci 1984;11:534-40.
11. Calore EE, Alonso Neto JL, Cavaliere MJ, Perez NM, Russo DH, Wakamatsu A, et al. Hypertrophic motor and sensory neuropathy type I (Charcot-Marie-Tooth disease): Ultrastructural study of sural nerve biopsy in members of a family. Pathologica 1994;86:279-83.
12. Choi SK, Bowers RP, Buckthal PE. MR imaging in hypertrophic neuropathy: A case of hereditary motor and sensory neuropathy, type I (Charcot-Marie-Tooth). Clin Imag 1990;14:204-7.
13. Friedman DP, Flanders AE, Tartaglino LM. Hypertrophic Charcot-Marie-Tooth disease: MR imaging findings. Am J Roentgenol 1994;163:749-50.
14. Valentijn LJ, Baas F, Zorn I, Hensels GW, de Visser M, Bolhuis PA. Alternatively sized duplication in Charcot-Marie-Tooth disease type 1A. Hum Mol Genet 1993;2:2143-6.
15. Hoogendijk JE, Hensels GW, Gabreels-Festen AA, Gabreels FJ, Janssen EA, de Jonghe P, et al. De-novo mutation in hereditary motor and sensory neuropathy type I. Lancet 1992;339:1081-2.
16. Hallam PJ, Harding AE, Berciano J, Barker DF, Malcolm S. Duplication of part of chromosome 17 is commonly associated with hereditary motor and sensory neuropathy type I (Charcot-Marie-Tooth disease type 1). Ann Neurol 1992;31:570-2.
17. Chance PF, Bird TD, Matsunami N, Lensch MW, Brothman AR, Feldman GM. Trisomy 17p associated with Charcot-Marie-Tooth neuropathy type 1A phenotype: Evidence for gene dosage as a mechanism in CMT1A. Neurology 1992;42:2295-9.
18. Upadhyaya M, Roberts SH, Farnham J, MacMillan JC, Clarke A, Heath JP, et al. Charcot-Marie-tooth disease 1A (CMTlA) associated with a maternal duplication of chromosome 17p11.2->12. Hum Genet 1993;91:392-4.
19. Lupski JR, Wise CA, Kuwano A, Pentao L, Parke JT, Glaze DG, et al. Gene dosage is a mechanism for Charcot-Marie-Tooth disease type 1A. Nat Genet 1992;1:29-33.
20. Roa BB, Lupski JR. Molecular genetics of Charcot-Marie-Tooth neuropathy. Adv Hum Genet 1994;22:117-52.
21. Matsunami N, Smith B, Ballard L, Lensch MW, Robertson M, Albertsen H, et al. Peripheral myelin protein-22 gene maps in the duplication in chromosome 17p11.2 associated with Charcot-Marie-Tooth 1A. Nat Genet 1992;1:176-9.
22. Timmerman V, Nelis E, Van Hul W, Nieuwenhuijsen BW, Chen KL, Wang S, et al. The peripheral myelin protein gene PMP-22 is contained within the Charcot-Marie-Tooth disease type 1A duplication. Nat Genet 1992;1:171-5.
23. Valentijn LJ, Baas F, Wolterman RA, Hoogendijk JE, van den Bosch NH, Zorn I, et al. Identical point mutations of PMP-22 in Trembler-J mouse and Charcot-Marie-Tooth disease type 1A. Nat Genet 1992;2:288-91.
24. Patel PI, Roa BB, Welcher AA, Schoener-Scott R, Trask BJ, Pentao L, et al. The gene for the peripheral myelin protein PMP-22 is a candidate for Charcot-Marie-Tooth disease type 1A. Nat Genet 1992;1:159-65.
25. Magyar JP, Martini R, Ruelicke T, Aguzzi A, Adlkofer K, Dembic Z, et al. Impaired differentiation of Schwann cells in transgenic mice with increased PMP 22 gene dosage. J Neurosci 1996 16:5351-60.
26. Roa BB, Dyck PJ, Marks HG, Chance PF, Lupski JR. Dejerine-Sottas syndrome associated with point mutation in the peripheral myelin protein 22 (PMP22) gene. Nat Genet 1993;5:269-73.
27. Nelis E, Timmerman V, De Jonghe P, Van Broeckhoven C. Identification of a 5′ splice site mutation in the PMP-22 gene in autosomal dominant Charcot-Marie-Tooth disease type 1. Hum Mol Genet 1994;3:515-6.
28. Roa BB, Garcia CA, Pentao L, Killian JM, Trask BJ, Suter U, et al. Evidence for a recessive PMP22 point mutation in Charcot-Marie-Tooth disease type 1A. Nat Genet 1993;5:189-94.
29. Suter U, Welcher AA, Ozcelik T, Snipes GJ, Kosaras B, Francke U, et al. Trembler mouse carries a point mutation in a myelin gene. Nature 1992;356:241-4.
30. Valentijn LJ, Baas F, Wolterman RA, Hoogendijk JE, van den Bosch NH, Zorn I, et al. Identical point mutations of PMP-22 in Trembler-J mouse and Charcot-Marie-Tooth disease type 1A. Nat Genet 1992;2:288-91.
31. Gabreels-Festen AA, Bolhuis PA, Hoogendijk JE, Valentijn LJ, Eshuis EJ, Gabreels FJ. Charcot-Marie-Tooth disease type 1A: Morphological phenotype of the 17p duplication versus PMP22 point mutations. Acta Neuropathol 1995;90:645-9.
32. 0 gene. Nat Genet 1993;5:31-4.
33. Latour P, Blanquet F, Nelis E, Bonnebouche C, Chapon F, Diraison P, et al. Mutations in the myelin protein zero associated with Charcot-Marie-Tooth disease type 1B. Hum Mutat 1995;6:50-4.
34. Nelis E, Timmerman V, De Jonghe P, Muylle L, Martin JJ, Van Broeckhoven C. Linkage and mutation analysis in an extended family with Charcot-Marie-Tooth disease type 1B. J Med Genet 1994;31:811-5.
35. 0 gene. Hum Genet 1994;94:653-7.
36. Thomas FP, Lebo RV, Rosoklija G, Ding XS, Lovelace RE, Latov N, et al. Tomaculous neuropathy in chromosome 1 Charcot-Marie-Tooth syndrome. Acta Neuropathol 1994;87:91-7.
37. 0 gene in Charcot-Marie-Tooth disease type 1B. Nat Genet 1993;5:35-9.
38. Hayasaka K, Himoro M, Wang Y, Takata M, Minoshima S, Shimizu N, et al. Structure and chromosomal localization of the gene encoding the human myelin protein zero (MPZ). Genomics 1993;17:755-8.
39. 0 gene in Charcot-Marie-Tooth neuropathy type 1. Biochem Biophys Res Commun 1993;194:1317-22.
40. 0 gene in Charcot-Marie-Tooth neuropathy type 1B. Hum Mol Genet 1993;2:1369-72.
41. Ollagnon E, Dautigny A, Pham-Dinh D, Chazot G. Mutations in the myelin protein zero gene associated with Charcot-Marie-Tooth disease type 1B. Hum Mutat 1995;6:50-4.
42. 0 gene in a pedigree of Charcot-Marie-Tooth neuropathy 1. Biochem Mol Biol Int 1993;31:169-73S.
43. 0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies. Nat Genet 1995;11:281-6.
44. Chance PF, Matsunami N, Lensch W, Smith B, Bird TD. Analysis of the DNA duplication 17p11.2 in Charcot-Marie-Tooth neuropathy type 1 pedigrees: Additional evidence for a third autosomal CMT1 locus. Neurology 1992;42:2037-41.
45. James R, Bellone E, Nelis E, Mandich P, Schenone A, Mancardi G, et al. Molecular analysis of three cases with hereditary motor and sensory neuropathy with myelin outfolding. Neurosci Lett 1995;194:136-8.
46. Umehara F, Takenaga S, Nakagawa M, Takahashi K, Izumo K, Matsumuro K, et al. Dominandy inherited motor and sensory neuropathy with excessive myelin folding complex. Acta Neuropathol 1993;86:602-8.
47. Kaku DA, Parry GJ, Malamut R, Lupski JR, Garcia CA. Uniform slowing of conduction velocities in Charcot-Marie-Tooth polyneuropathy type 1. Neurology 1993;43:2664-7.
48. Kaku DA, Parry GJ, Malamut R, Lupski JR, Garcia CA. Nerve conduction studies in Charcot-Marie-Tooth polyneuropathy associated with a segmental duplication of chromosome 17. Neurology 1993;43:1806-8.
49. Nicholson GA. Penetrance of the hereditary motor and sensory neuropathy Ia mutation: Assessment by nerve conduction studies. Neurology 1991;41:547-52.
50. Hoogendijk JE, De Visser M, Bolhuis PA, Hart AA, Ongerboer de Visser BW. Hereditary motor and sensory neuropathy type I: Clinical and neurographical features of the 17p duplication subtype. Muscle Nerve 1994;17:85-90.
51. Killian JM, Tiwari PS, Jacobson S, Jackson RD, Lupski JR. Longitudinal studies of the duplication form of Charcot-Marie-Tooth polyneuropathy. Muscle Nerve 1996;19:74-8.
52. Roy EP III, Gutmann L, Riggs JE. Longitudinal conduction studies in hereditary motor and sensory neuropathy type I. Muscle Nerve 1989;12:52-5.
53. Pareyson D, Sghirlanzoni A. Conduction velocities in Charcot-Marie-Tooth polyneuropathy type 1. Neurology 1994;44:2216.
54. Lutschg J, Muller HJ, Malik NJ. The value of family investigations in newly detected Charcot-Marie-Tooth disease in children. Eur J Pediatr 1995;154:S40-3.
55. Garcia CA, Malamut RE, England JD, Parry GS, Liu P, Lupski JR. Clinical variability in two pairs of identical twins with the Charcot-Marie-Tooth disease type 1A duplication. Neurology 1995;45:2090-3.
56. Mancardi GL, Uccelli A, Bellone E, Sghirlanzoni A, Mandich P, Pareyson D, et al. 17p11.2 Duplication is a common finding in sporadic cases of Charcot-Marie-Tooth type 1. Eur Neurol 1994;34: 135-9.
57. Wise CA, Garcia CA, Davis SN, Heju Z, Pentao L, Patel PI, et al. Molecular analyses of unrelated Charcot-Marie-Tooth (CMT) disease patients suggest a high frequency of the CMTIA duplication. Am J Hum Genet 1993;53:853-63.
58. Gabreels-Festen AA, Gabreels FJ, Hoogendijk JE, Bolhuis PA, Jongen PJ, Vingerhoets HM. Chronic inflammatory demyelinating polyneuropathy or hereditary motor and sensory neuropathy? Diagnostic value of morphological criteria. Acta Neuropathol 1993;86:630-5.
59. Graf WD, Chance PF, Lensch MW, Eng LJ, Lipe HP, Bird TD. Severe vincristine neuropathy in Charcot-Marie-Tooth disease type 1A. Cancer 1996;77:1356-62.
60. Hogan-Dann CM, Fellmeth WG, McGuire SA, Kiley VA. Polyneuropathy following vincristine therapy in two patients with Charcot-Marie Tooth syndrome. JAMA 1984;252:2862-3.
61. Dickerhoff R, Lindner W, Scheiber W. Severe vincristine neurotoxicity in a patient with Charcot-Marie-Tooth disease. Pediatr Hematol Oncol 1988;5:61-4.
62. Neumann Y, Toren A, Rechavi G, Seifried B, Shoham NG, Mandel M, et al. Vincristine treatment triggering the expression of asymptomatic Charcot-Marie-Tooth disease. Med Pediatr Oncol 1996;26: 280-3.
63. Igarashi M, Thompson EI, Rivera GK. Vincristine neuropathy in type I and type II Charcot-Marie-Tooth disease (hereditary motor sensory neuropathy). Med Pediatr Oncol 1995;25:113-6.
64. Chance PF, Alderson MK, Leppig KA, Lensch MW, Matsunami N, Smith B, et al. DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 1993;72:143-51.
65. Adlkofer K, Martini R, Aguzzi A, Zielasek J, Toyka KV, Suter U. Hypermyelination and demyelinating peripheral neuropathy in PMP22-deficient mice. Nat Genet 1995;11:274-80.
66. Verhalle D, Lofgren A, Nelis E, Dehaene I, Theys P, Lammens M, et al. Deletion in the CMT1A locus on chromosome 17p11.2 in hereditary neuropathy with liability to pressure palsies. Ann Neurol 1994;35:704-8.
67. Lorenzetti D, Pareyson D, Sghirlanzoni A, Roa BB, Abbas NE, Pandolfo M, et al. A 1.5-Mb deletion in 17p11.2-p12 is frequently observed in Italian families with hereditary neuropathy with liability to pressure palsies. Am J Hum Genet 1995;56:91-8.
68. Mariman EC, Gabreels-Festen AA, van Beersum SE, Valentijn LJ, Baas F, Bolhuis PA, et al. Prevalence of the 1.5-Mb 17p deletion in families with hereditary neuropathy with liability to pressure palsies. Ann Neurol 1994;36:650-5.
69. Le Guem E, Sturtz F, Gugenheim M, Gouider R, Bonnebouche C, Ravise N, et al. Detection of deletion within 17p11.2 in 7 French families with hereditary neuropathy with liability to pressure palsies (HNPP). Cytogenet Cell Genet 1994;65:261-4.
70. Chance PF, Abbas N, Lensch MW, Pentao L, Roa BB, Patel PI, et al. Two autosomal dominant neuropathies result from reciprocal DNA duplication/deletion of a region on chromosome 17. Hum Mol Genet 1994;3:223-8.
71. Lopes J, LeGuem E, Gouider R, Tardieu S, Abbas N, Birouk N, et al. Recombination hot spot in a 3.2-kb region of the Charcot-Marie-Tooth type 1A repeat sequences: New tools for molecular diagnosis of hereditary neuropathy with liability to pressure palsies and of Charcot-Marie-Tooth. Am J Hum Genet 1996;58:1223-30.
72. Reiter LT, Murakami T, Koeuth T, Pentao L, Muzny DM, Gibbs RA, et al. A recombination hotspot responsible for two inherited peripheral neuropathies is located near a mariner transposon-like element. Nat Genet 1996;12:288-97.
73. Kiyosawa H, Lensch MW, Chance PF. Analysis of the CMT1A-REP repeat: Mapping crossover breakpoints in CMT1A and HNPP. Hum Mol Genet 1995;4:2327-34.
74. Benstead TJ, Kuntz NBL, Miller RG, Daube JR. The electrophysiologic profile of Dejerine Sottas disease (HMSN III). Muscle Nerve 1990;13:586-92.
75. Tachi N, Kozuka N, Ohya K, Chiba S, Naganuma M. MRI of peripheral nerves and pathology of sural nerves in hereditary motor and sensory neuropathy type III. Neuroradiology 1995;37:496-9.
76. Gabreels-Festen AA, Gabreels FJ, Jennekens FG, Janssen-van Kempen TW. The status of HMSN type III. Neuromusc Disord 1994;4:63-9.
77. Malandrini A, De Stefano N, Dotti MT, Vecchione V, Federico A. Sensory-motor hereditary neuropathy with early onset: A case report. Acta Neurol 1993;15:81-6.
78. Ouvrier RA, Mcleod JG, Conchin TE. The hypertrophic features of hereditary motor and sensory neuropathy: A study of hypertrophic Charcot-Marie-Tooth disease (HMSN type 1) and Dejerine-Sottas disease (HMSN< type III) in childhood. Brain 1987;110:121-48.
79. Moss RB, Sriram S, Kelts KA, Forno LS, Lewiston NJ. Chronic neuropathy presenting as a floppy infant with respiratory distress. Pediatrics 1979;64:459-64.
80. Felice KJ, Fratkin JD, Feldman EL, Sima AA. Phrenic nerve involvement in Dejerine-Sottas disease: A clinical pathological case study. Pediatr Pathol 1994;14:905-11.
81. Kouavaras G, Chronopoulos G, Pistis G, Cokkinos D. Hypertrophic peripheral neuropathy (Dejerine-Sottas disease) associated with heart block: Case report presentation and review of the literature. Jpn Heart J 1990;31:405-10.
82. Masuda N, Hayashi H, Tanabe H. Nerve root and sciatic trunk enlargement in Dejerine-Sottas disease: MRI appearance. Neuroradiology 1992;35:36-7.
83. Carlin L, Biller J, Challa V, Riela A. Hypertrophic neuropathy with spinal cord compression. Surg Neurol 1982;18:237-40.
84. Barbieri F, Santangelo R, Bonuso S, Chiacchio L, Santoro L, Crisci C, et al. A case of Dejerine Sottas disease with prominent ataxia and brainstem involvement: A clinical, electrophysiological, otoneurologic, and ultrastructural study. Clin Neurol Neurosurg 1987;89: 287-92.
85. Baiocco F, Testa D, d'Angelo A, Cocchini F. Abnormal auditory evoked potentials in Dejerine-Sottas disease: Report of two cases with central acoustic and vestibular impairment. J Neurol 1984;231: 46-9.
86. 0 in a patient with a Dejerine-Sottas syndrome (DSS) phenotype. Hum Mol Genet 1994;3:1701-2.
87. 0 gene in Dejerine-Sottas disease (hereditary motor and sensory neuropathy type III). Nat Genet 1993;5:266-8.
88. 0 gene producing Dejerine-Sottas disease (hereditary motor and sensory neuropathy type III). Biochem Biophys Res Commun 1996;222:107-10.
89. Roa BB, Garcia CA, Suter U, Kulpa DA, Wise CA, Mueller J, et al. Charcot-Marie-Tooth disease type 1A: Association with a spontaneous point mutation in the PMP22 gene. N Engl J Med 1993;329:96-101.
90. Ionasescu VV, Ionasescu R, Searby CC, Neahring R. Dejerine-Sottas disease with de novo dominant point mutation of PMP 22 gene. Neurology 1995;45:1766-7.
91. Killian JM, Kloepfer HW. Homozygous expression of a dominant gene for Charcot-Marie-Tooth neuropathy. Ann Neurol 1979;5:515-22.
92. 0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelination. Neuron 1997;17:451-60.
93. Ionasescu W, Kimura J, Searby CC, Smith WL, Ross M, Ionasescu RA. Dejerine-Sottas neuropathy family with a gene mapped on chromosome 8. Muscle Nerve 1996;19:319-23.
94. Lynch DR, Hara H, Yum S, Chance PF, Scherer SS, Bird SJ, et al. Autosomal dominant transmission of Dejerine Sottas disease (HMSN III). Neurology. In press.
95. Sghirlanzoni A, Pareyson D, Balestrini MR, Bellone E, Berta E, Ciano C, et al. HMSN III phenotype due to homozygous expression of a dominant HMSN II gene. Neurology 1992;42:2201-4.
96. Sabatelli, M, Mignogna T, Lippi G, Servidei S, Manfredi G, Ricci E, et al. Autosomal recessive hypermyelinating neuropathy. Acta Neuropathol 1994;87:337-42.
97. Gabreels Festen AA, Gabreels FJ, Jennekens FG, Joosten EM, Janssen-van Kempen TW. Autosomal recessive form of hereditary motor and sensory neuropathy type I. Neurology 1992;42:1755-61.
98. Ben Othmane K, Hentati F, Lennon F, Ben Hamida C, Blel S, Roses AD, et al. Linkage of a locus (CMT4A) for autosomal recessive Charcot-Marie-Tooth disease to chromosome 8q. Hum Mol Genet 1993;2:1625-8.
99. Othmane KB, Loeb D, Hayworth-Hodgte R, Hentati F, Rao N, Roses AD, et al. Physical and genetic mapping of the CMT4A locus and exclusion of PMP-2 as the defect in CMT4A. Genomics 1995;28:286-90.
100. Schenone A, Abbrizzese M, Uccelli A, Mandich P, James R, Bellone E, et al. Hereditary motor and sensory neuropathy with myelin outfolding: Clinical, genetic and neuropathological study of three cases. J Neurol Sci 1994;122:20-7.
101. Bolino A, Brancolini V, Bono F, Bruni A, Gambardella A, Romeo G, et al. Localization of a gene responsible for autosomal recessive demyelinating neuropathy with focally folded myeli sheaths to chromosome 11q23 by homozygosity mapping and hapltype analysis. Hum Mol Genet 1996;5:1051-4.
102. Harding AE, Thomas PK. Autosomal recessive forms of hereditary motor and sensory neuropathy. J Neurol Neurosurg Psychiatry 1980;43:669-78.
103. Fryns JP, Van Den Berghe H. Sex linked recessive inheritance in Charcot-Marie-Tooth disease with partial manifestations in female carriers. Hum Genet 1980;55:413-5.
104. Phillips LH, Kelly TE, Schnatterly P, Parker D. Hereditary motorsensory neuropathy (HMSN): Possible X-linked dominant inheritance. Neurology 1985;35:498-502.
105. Nicholson G, Nash J. Intermediate nerve conduction velocities define X-linked Charcot-Marie-Tooth neuropathy families. Neurology 1993;43:2558-64.
106. Bergoffen J, Scherer SS, Wang S, Scott MO, Bone LJ, Paul DL, et al. Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 1993 262:2039-42.
107. Ionasescu V, Searby C, Ionasescu R. Point mutations of the connexin 32. (GJB1) gene in X-linked dominant Charcot-Marie-Tooth neuropathy. Hum Mol Genet 1994;3:355-8.
108. Ionasescu V, Searby C, Ionasescu R, Meschino W. New point mutations and deletions of the connexin 32 gene in X-linked Charcot-Marie-Tooth neuropathy. Neuromusc Dis 1995;5:297-9.
109. Orth U, Fairweather N, Exler MC, Schwinger E, Gal A. X-linked dominant Charcot-Marie-Tooth neuropathy: Valine-38-methionine substitution of connexin 32. Hum Mol Genet 1994;3:1699-700.
110. Cochrane S, Bergoffen J, Fairweather ND, Muller E, Mostacciuolo ML, Monaco AP, et al. X linked Charcot-Marie-Tooth disease (CMTX1): A study of 15 families with 12 highly informative polymorphisms. J Med Genet 1994;31:193-6.
111. Fairweather N, Bell C, Cochrane S, Chelly J, Wang S, Mostacciuolo ML, et al. Mutations in the connexin 32 gene in X-linked dominant Charcot-Marie-Tooth disease (CMTX1). Hum Mol Genet 1994;3:29-34.
112. Paul DL. New functions for gap junctions. Curr Opin Cell Biol 1995;7:665-72.
113. Spray DC, Dermietzel R. X-linked dominant Charcot-Marie-Tooth disease and other potential gap-junction diseases of the nervous system. Trends Neurosci 1995;18:256-62.
114. Bone LJ, Dahl N, Lensch MW, Chance PF, Kelly T, Le Guern E, et al. New connexin 32 mutations associated with X-linked Charcot-Marie-Tooth disease. Neurology 1995;45:1863-6.
115. Bruzzone R, White TW, Scherer SS, Fischbeck KH, Paul DL. Null mutations of connexin 32 in patients with X-linked Charcot-Marie-Tooth. Neuron 1994;13:1253-60.
116. Rabadan-Diehl C, Dahl G, Werner R. A connexin-32 mutation associated with Charcot-Marie-Tooth disease does not affect channel formation in oocytes. FEBS Lett 1994;351:90-4.
117. Gilchrist D, Chan CK, Deck JH. Phrenic involvement in Charcot-Marie-Tooth disease: A pathologic documentation. Chest 1989;96: 1197-9.
118. Gabreels-Festen AA, Joosten EM, Gabreels FJ, Jennekens FG, Gooskens RG, Stegman DF. Hereditary motor and sensory neuropathy of neuronal type with onset in early childhood. Brain 1991;114:1855-70.
119. Vogel P, Gabriel M, Goebel HH, Dyck PJ. Hereditary motor sensory neuropathy type II with neurofilament accumulation: New finding or new disorder. Ann Neurol 1985;17:455-61.
120. Yoshioka R, Dyck PJ, Chance PF. Genetic heterogeneity in Charcot-Marie-Tooth neuropathy type 2. Neurology 1996;46:569-71.
121. Timmerman V, De Jonghe P, Spoelders P, Simokovic S, Lofgren A, Nelis E, et al. Linkage and mutation analysis of Charcot-Marie-Tooth neuropathy type 2 families with chromosomes 1p35-p36 and Xq13. Neurology 1996;46:1311-8.
122. Ben Othmane K, Middleton LT, Loprest LJ, Wilkinson KM, Lennon F, Rozear MP, et al. Localization of a gene (CMT 2A) for autosomal dominant Charcot-Marie-Tooth disease type 2 to chromosome 1p and evidence of genetic heterogeneity. Genomics 1995;17:370-5.
123. Kwon JM, Elliott JL, Yee WC, Ivanovich J, Scavarda NJ, Moolsintong PJ, et al. Assignment of a second Charcot-Marie-Tooth type II locus to chromosome 3q. Am J Hum Genet 1995;57:853-8.
124. Dyck PJ, Litchy WJ, Minnerath S, Bird TD, Chance PF, Schaid DJ, Aronson AE. Hereditary motor and sensory neuropathy with diaphragm and vocal cord paresis. Ann Neurol 1994;35:608-15.
125. Ionesescu V, Searby C, Sheffield VC, Roklina T, Nishimura D, Ionasescu R. Autosomal dominant Charcot-Marie-Tooth axonal neuropathy mapped on chromosome 7p (CMT2D). Hum Mol Genet 1996;5:1373-5.
126. Harding AE, Thomas PK. Peroneal muscular atrophy with pyramidal features. J Neurol Neurosurg Psychiatry 1984;47:168-72.
127. Schnider A, Hess CM, Koppi S. Central motor conduction in a family with hereditary motor and sensory neuropathy with pyramidal signs (HMSN V). J Neurol Neurosurg Psychiatry 1991;54:511-5.
128. Izumi Y, Fukuuchi Y, Koto A, Ishihara N, Tachibana H. Spastic paraplegia with amyotrophy of the legs: A rare case of motor and sensory neuropathy. Keio J Med 1994;43:206-10.
129. Ippel EF, Wittebol-Post D, Jennekens FG, Bijlsma JB. Genetic heterogeneity of hereditary motor and sensory neuropathy type VI. J Child Neurol 1995;10:459-63.
130. Weiller C, Ferbert A. Hereditary motor and sensory neuropathy (HMSN) and optic atrophy (HMSN type VI, Vizioli). Eur Arch Psychiatry Clin Neurosci 1991;240:246-9.
131. Bottachi E, Nemni R, Camerlingo M, Gambaro P, Corbo M, Mamoli A. Hereditary motor neuropathy, distal type: Electrophysiological and pathological studies of a case. Ital J Neurol Sci 1985;6:513-6.
132. Timmerman V, Raeymakers P, Nelis E, De Jonghe P, Muylle L, Ceuterlick C, et al. Linkage analysis of distal hereditary motor neuropathy type II (distal HMN II) in a single pedigree. J Neurol Sci 1992;109:41-8.
133. Boylan KB, Comblath DR, Glass JD, Alderson K, Kuncl RW, Kleyn PW, et al. Autosomal dominant distal spinal muscular atrophy in four generations. Neurology 1995;45:699-704.
134. Chance PF, Lensch MW, Lipe H, Brown RH Sr, Brown RH Jr, Bird TD. Hereditary neuralgic amyotrophy and hereditary neuropathy with liability to pressure palsies: Two distinct generic disorders. Neurology 1994;44:2253-7.
135. Hara M, Ichida F, Higuchi A, Tanizawa T, Okada T. Nephropathy associated with Charcot-Marie-Tooth disease. Int J Pediatr Nephrol 1984:5:99-102.
136. Ruiz C, Rivas F, Ramirez-Casillas G, Vazquez-Santana R, Mendoza-Chalita B, Feria-Velasco A, et al. A distinct congenital motor and sensory neuropathy (neuronal type) with dysmorphic features in a father and two sons: A variant of Charcot Marie Tooth disease. Clin Genet 1987;31:109-13.
137. Hamiel OP, Raas-Rothschild A, Upadhyaya M, Frydman M, Sarova-Pinhas I, Brand N, et al. Hereditary motor-sensory neuropathy (Charcot-Marie-Tooth disease) with nerve deafness: A new variant. J Pediatr 1993;123:431-4.
138. Gibberd FB, Billimoria JD, Goldman JM, Clemens ME, Evans R, Whitelaw MN, et al. Heredopathia atactica polyneuritiformis: Refsum's disease. Acta Neurol Scand 1985;72:1-17.
139. Brink HJ, Schor DS, Kok RM, Poll BT, Wanders RJ, Jakobs C. Phytanic acid alpha-oxidation: Accumulation of 2-hydroxyphytanic acid and absence of 2-oxophytanic acid in plasma from patients with peroxisomal disorders. J Lipid Res 1992;33:1449-57.
140. Tuck RR, McLeod JG. Retinitis pigmentosa, ataxia, and peripheral neuropathy. J Neurol Neurosurg Psychiatry 1983;46:206-13.
141. Nakata T, Shimamoto K, Yonekura S, Kobayashi N, Sugiyama T, Imai K, Iimura O. Cardiac sympathetic denervation in transthyretin-related familial amyloidotic polyneuropathy: Detection with iodine-123-MIBG. J Nucl Med 1995;36:1040-2.
142. Fiori MG, Salvi F, Plasmati R, Tessari F, Bianchi R, Tassinari CA. Amyloid deposits inside myocardial fibers in transthyretin-Met30 familial amyloidotic polyneuropathy: A histological and biochemical study. Cardiology 1994;85:145-53.
143. Ghiso J, Wisniewski T, Frangione B. Unifying features of systemic and cerebral amyloidosis. Mol Neurobiol 1994;8:49-64.
144. Bhatia K, Reilly M, Adams D, Davis MB, Hawkes CH, Thomas PK, et al. Transthyretin gene mutations in British and French patients with amyloid neuropathy. J Neurol Neurosurg Psychiatry 1993;56:694-7.
145. Izumoto S, Younger D, Hays AP, Tone RL, Smith RT, Herbert J. Familial amyloidotic polyneuropathy presenting with carpal tunnel syndrome and a new transthyretin mutation, asparagine 70. Neurology 1992;42:2094-102.
146. Murakami T, Tachibana S, Endo Y, Kawai R, Hara M, Tanase S, et al. Familial carpal tunnel syndrome due to amyloidogenic transthyretin His 114 variant. Neurology 1994;44:315-8.
147. Murakami T, Uchino M, Ando M. Genetic abnormalities and pathogenesis of familial amyloidotic polyneuropathy. Pathol Int 1995;45:1-9.
148. Uemichi T, Gertz MA, Benson MD. Amyloid polyneuropathy in two German-American families: A new transthyretin variant (Val 107). J Med Genet 1994;31:416-7.
149. Ando E, Ando Y, Uoka S, Sakai Y, Watanabe S, Yamashita R, et al. Ocular microangiopathy in familial amyloidotic polyneuropathy, type I. Graefes Arch Clin Exp Ophthalmol 1992;230:l-5.
150. Gertz MA, Kyle RA, Thibodeau SN. Familial amyloidosis: A study of 52 North American-born patients examined during a 30-year period. Mayo Clinic Proc 1992;67:428-40.
151. Simmons Z, Blaivas M, Aguilera AJ, Feldman EL, Bromberg MB, Towfighi J. Low diagnostic yield of sural nerve biopsy in patients with peripheral neuropathy and primary amyloidosis. J Neurol Sci 1993;120:60-3.
152. Booth DR, Tan SY, Hawkins PN, Pepys MB, Frustaci A. A novel variant of transthyretin, 59Thr->Lys, associated with autosomal dominant cardiac amyloidosis in an Italian family. Circulation 1995;91:962-7.
153. Vidal R, Garzuly F, Budka H, Lalowski M, Linke RP, Brittig F, et al. Meningocerebrovascular amyloidosis associated with a transthyretin mis-sense mutation at codon 18 (TTRD 18G). Am J Pathol 1996;148:361-6.
154. Saraiva MJ. Transthyretin mutations in health and disease. Hum Mutat 1995;5:191-6.
155. Salvi F, Salvi G, Volpe R, Mencucci R, Plasmati R, Michelucci R, et al. Transthyretin-related TTR hereditary amyloidosis of the vitreous body: Clinical and molecular characterization in two Italian families. Ophthalmol Paediatr Genet 1993;14:9-16.
156. Kincaid JC, Wallace MR, Benson MD. Late onset familial amyloid polyneuropathy in an American family of English origin. Neurology 1989;39:861-3.
157. Ii S, Somber SS. The high frequency of TTR M30 in familial amyloidotic polyneuropathy is not due to a founder effect. Hum Mol Genet 1993;2:1303-5.
158. Varga J, Wohlgethan JR. The clinical and biochemical spectrum of hereditary amyloidosis. Semin Arthritis Rheum 1988;18:14-28.
159. Jacobson DR, Alves IL, Saraiva MJ, Thibodeau SN, Buxbaum JN. Transthyretin Ser 6 gene frequency in individuals without amyloidosis. Hum Genet 95:308-12.
160. Torres M F, Almeida MR, Saraiva MJ. TTR exon scanning in peripheral neuropathies. Neuromusc Disord 1995;5:187-91.
161. Harding AE. Molecular genetics of peripheral neuropathies. Ballieres Clin Neurol 1995;4:383-400.
162. Haltia M, Levy E, Meretoja J, Fernandez-Madrid I, Koivunen O, Frangione B. Gelsolin gene mutation-at codon 187- in familial amyIoidosis: Finnish DNA-Diagnostic assay. Am J Med Genet 1992;42: 357-9.
163. Cohen AS. Clinical aspects of amyloidosis, including related proteins and central nervous system amyloidosis. Curr Opin Rheum 1994;6:68-77.
164. Holmgren G, Costa PM, Andersson C, Asplund K, Steen L, Beckman L, et al. Geographical distribution of TTR met30 carriers in northern Sweden: Discrepancy between carrier frequency and prevalence rate. J Med Genet 1994;31:351-4.
165. Holmgren G, Bergstrom S, Drugge U, Lundgren E, Nording-Sikstrom C, Sandgren O, et al. Homozygosity for the transthyretin-Met30-gene in seven individuals with familial amyloidosis with polyneuropathy detected by restriction enzyme analysis of amplified genomic DNA sequences. Clin Genet 1992;41:39-41.
166. Ikeda S, Nakano T, Yanagisawa N, Nakazato M, Tsukagoshi H. Asymptomatic homozygous gene carrier in a family with type I familial amyloid polyneuropathy. Eur Neurol 1992;32:308-13.
167. Yoshinaga T, Nakazato M, Ikeda S, Ohnishi A. Homozygosity for the transthyretin-Met30 gene in three Japanese siblings with type I familial amyloidotic polyneuropathy. Neurology 1992;42:2045-7.
168. Monaco HL, Rizzi M, Coda A. Structure of a complex of two plasma proteins: Transthyretin and retinol-binding protein. Science 1995;268:1039-41.
169. Berni R, Malpeli G, Folli C, Murrell JR, Liepnieks JJ, Benson MD. The Ile-84→Ser amino acid substitution in transthyretin interferes with the interaction with plasma retinol-binding protein. J Biol Chem 1994;269:23395-8.
170. Episkopou V, Maeda S, Nishiguchi S, Shimada K, Gaitanaris GA, Gottesman ME, et al. Disruption of the transthyretin gene results in mice with depressed levels of plasma retinol and thyroid hormone. Proc Nad Acad Sci USA 1993;90:2375-9.
171. Wei S, Episkopou V, Piantedosi R, Maeda S, Shimada K, Gottesman ME, et al. Studies on the metabolism of retinol and retinol-binding protein in transthyretin-deficient mice produced by homologous recombination. J Biol Chem 270:866-70.
172. Palha JA, Episkopou V, Maeda S, Shimada K, Gottesman ME, Saraiva MJ. Thyroid hormone metabolism in a transthyretin-null mouse strain. J Biol Chem 1994;269:33135-9.
173. Gustavsson A, Engstrom U, Westermark P. Normal transthyretin and synthetic transthyretin fragments form amyloid-like fibrils in vitro. Biochem Biophys Res Commun. 1991;175:1159-64.
174. Terry CJ, Damas AM, Oliveira P, Saraiva MJ, Alves IL, Costa PP, et al. Structure of Met30 variant of transthyretin and its amyloidogenic implications. EMBO J 1993;12:735-41.
175. McCutchen SL, Lai Z, Miroy GJ, Kelly JW, Colon W. Comparison of lethal and nonlethal transthyretin variants and their relationship to amyloid disease. Biochemistry 1995;34:13527-36.
176. McCutchen SL, Kelly JW. Intermolecular disulfide linkages are not required for transthyretin amyloid fibril formation in vitro. Biochem Biophys Res Commun 1993;197:415-21.
177. Colon W, Kelly JW. Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. Biochemistry 1992;31:8654-60.
178. McCutchen SL, Colon W, Kelly JW. Transthyretin mutation Leu55-Pro significantly alters tetramer stability and increases amyloidogenicity. Biochemistry 1993;32:12119-27.
179. Araki S, Yi S, Murakami T, Watanabe S, Ikegawa S, Takahashi K, et al. Systemic amyloidosis in transgenic mice carrying the human mutant transthyretin (Met 30) gene: Pathological and immunohistochemical similarity to human familial amyloidotic polyneuropathy, type I. Mol Neurobiol 1994;8:15-23.
180. Reilly MM, Staunton H, Harding AE. Familial amyloid polyneuropathy (TTR ala 60) in north west Ireland: a clinical, genetic, and epidemiological study. J Neurol Neurosurg Psychiatry 1995;59:45-9.
181. Sousa A, Andersson R, Drugge U, Holmgren G, Sandgren O. Familial amyloidotic polyneuropathy in Sweden: Geographical distribution, age of onset, and prevalence. Hum Hered 1993;43:288-94.
182. Hardell L, Holmgren G, Steen L, Fredrikson M, Axelson O. Occupational and other risk factors for clinically overt familial amyloid polyneuropathy. Epidemiology 1995;6:598-601.
183. Holmgren G, Steen L, Ekstedt J, Groth CG, Ericzon BG, Eriksson S, et al. Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met 30). Clin Genet 1991;40:242-6.
184. Suhr OB, Holmgren G, Steen L, Wikstrom L, Norden G, Friman S, et al. Liver transplantation in familial amyloidotic polyneuropathy: Follow-up of the first 20 Swedish patients. Transplantation 1995;60:933-8.
185. Lewis WD, Skinner M, Simms RW, Jones LA, Cohen AS, Jenkins RL. Orthotopic liver transplantation for familial amyloidotic polyneuropathy. Clin Transplant 1994;8:107-10.
186. Ericzon BG, Suhr O, Broome U, Holmgren G, Duraj F, Eleborg L, et al. Liver transplantation halts the progress of familial amyloidotic polyneuropathy. Transplant Proc 1995;27:1233.
187. Ando Y, Tashima K, Tanaka Y, Nakazato M, Ericzon BG, Duraj FF, et al. Treatment of a Japanese patient with familial amyloidotic polyneuropathy with orthotopic liver transplantation. Intern Med 1994;33:730-2.
188. Howell N, Kubacka I, Smith R, Frerman F, Parks JK, Parker WD Jr. Association of the mitochondrial 8344 MERRF mutation with maternally inherited spinocerebellar degeneration and Leigh disease. Neurology 1996;46:219-22.
189. Coker SB. Leigh disease presenting as Guillain-Barre syndrome. Pediatr Neurol 1993;9:61-3.
190. Hirano M, Silvestri G, Blake DM, Lombes A, Minetti C, Bonilla E, et al. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): Clinical, biochemical, and genetic features of an autosomal recessive mitochondrial. Neurology 1994;44:721-7.
191. Schroder JM. Neuropathy associated with mitochondrial disorders. Brain Pathol 1993;3:177-90.
192. Kurlemann G, Paetzke I, Moller H, Masur H, Schuierer G, Weglage J, et al. Therapy of complex I deficiency: Peripheral neuropathy during dichloroacetate therapy. Eur J Pediatr. 1995;154:928-32.
193. Narayanan V, Ripepi B, Jabs EW, Hawkins A, Griffin C, Tennekoon G. Partial structure and mapping of the human myelin P2 protein gene. J Neurochem 1994;63:2010-3.
194. Griffiths IR, Montague P, Dickinson P. The proteolipid protein gene. Neuropathol Appl Neurobiol 1995;21:85-96.